Candice Matthews Brackeen will share her unique perspective on the challenges and opportunities that come from working in the venture capital space and collaborating with tech transfer professionals across the country. Currently based in the Cincinnati Innovation District on the University of Cincinnati campus, the birthplace of the Ohio IP Promise, Candice will provide valuable insights and engage in an inspiring and thought-provoking conversation with the audience. Don't miss this opportunity to learn from Candice's wealth of experience in the tech transfer and venture capital fields.
Candice is a General Partner at Lightship Capital, where she finds and funds high growth, minority-led companies operating in underserved ecosystems throughout the Midwest. Launched in 2020, Lightship Capital is raising a $50MM for investment into underrepresented founders operating in the CPG, E-Commerce, Sustainability, Artificial Intelligence, and Healthcare spaces. Candice is also the Founder and CEO at Lightship Foundation, the inclusion-focused entrepreneur enrichment program guiding minority founders with instruction in product development, brand building, leveraging artificial intelligence for business and fundraising.
Candice expands upon her work driving representation in innovation with her role on the Lunar Surface Innovation Consortium for NASA, where she leads diversity of thought as new cultures and economies are developed. She also sits on the advisory committee and selection committees for technology for the Ohio State University and Cincinnati Children's Hospital and Medical Center; ensuring that as technology is commercialized from these entities, diversity is at the forefront of decision making.
Get ready to hear lots of commercialization success stories as John delivers his keynote address on “95% Commercialization.” This is the success rate of his firm, Nottingham Spirk (NS), which far surpasses the national average of 5%. Learn about NS and their “Vertical Innovation Process” that has contributed to their outstanding commercialization rate. John will present their work with commercialization successes on so many everyday products, including a special initiative currently underway with NASA to commercialize a patent, and how federal labs can get more involved with companies like NS.
John Nottingham is Co-President of Nottingham Spirk (NS), a leading business and product innovation firm with over 1,350 patents, of which 95% have been commercialized. The Nottingham Spirk “Vertical Innovation Process” has helped client / partner companies earn over $50 billion in combined sales.
The NS innovation team has co-created such award-winning consumer and medical innovations as SpinBrush, the largest selling powered toothbrush line; Swiffer Sweep+Vac; Club Car Tempo Walk, world’s first autonomous golf caddie; Cardinal Health InPower Digital Medication Assistant; and Medtronic CardioInsight EC Vue, the first non-invasive electrocardiographic mapping system.
John is the co-founder of several venture companies based on technology transfers from universities, including TecTraum, the first concussion therapy system; Sterifre, disinfection technology and XaTek, blood coagulation monitor.
He serves on the Cleveland Clinic Board of Trustees, Case Western Reserve University Technology Commercialization Board, boards of CWRU think[box] maker space, Global Center for Health Innovation, Great Lakes Biomimicry, as well as several private equity company boards of directors.
John is a Fellow of the National Academy of Inventors. As the lead patent holder on hundreds of US and international patents, he is in the top tier of individual inventors in the US. He is an inductee of the Inside Business Hall of Fame and a Winner of the EY Entrepreneur of the Year Award.
John has presented numerous times on the subject of breakthrough innovation, and he has been featured on The Today Show, CNN, NBC Nightly News, CNBC, SiriusXM, Wall Street Journal, Fortune, Forbes, Japan Forbes, Bloomberg BusinessWeek, New York Times, Wired and Fast Company.